Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Murray A. Mittleman, Dr.P.H., M.D., D.Ec.

Co-Author

This page shows the publications co-authored by Murray Mittleman and Francine Welty.
Connection Strength

0.188
  1. Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population. Circulation. 1997 Feb 18; 95(4):825-30.
    View in: PubMed
    Score: 0.045
  2. A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction <50%. Circulation. 1996 Apr 15; 93(8):1496-501.
    View in: PubMed
    Score: 0.043
  3. Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia. Am J Cardiol. 1995 Sep 01; 76(7):431-5.
    View in: PubMed
    Score: 0.041
  4. Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia. J Am Coll Cardiol. 1994 Jan; 23(1):35-9.
    View in: PubMed
    Score: 0.036
  5. Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart. 1998 Sep; 80(3):235-9.
    View in: PubMed
    Score: 0.013
  6. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation. 1995 Apr 01; 91(7):1952-8.
    View in: PubMed
    Score: 0.010
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.